HomeCompareGBIO vs PLD

GBIO vs PLD: Dividend Comparison 2026

GBIO yields 37.45% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.71M in total portfolio value· pulled ahead in Year 7
10 years
GBIO
GBIO
● Live price
37.45%
Share price
$5.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$201.6K
Annual income
$32,248.55
Full GBIO calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — GBIO vs PLD

📍 PLD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBIOPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBIO + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GBIO pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBIO
Annual income on $10K today (after 15% tax)
$3,183.52/yr
After 10yr DRIP, annual income (after tax)
$27,411.27/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,010,705.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBIO + PLD for your $10,000?

GBIO: 50%PLD: 50%
100% PLD50/50100% GBIO
Portfolio after 10yr
$3.05M
Annual income
$2,391,486.86/yr
Blended yield
78.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

GBIO
Analyst Ratings
5
Buy
5
Hold
Consensus: Buy
Price Target
$5.25
-1.7% upside vs current
Range: $5.00 — $5.50
Altman Z
-9.1
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBIO buys
0
PLD buys
0
No recent congressional trades found for GBIO or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBIOPLD
Forward yield37.45%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$201.6K$5.91M
Annual income after 10y$32,248.55$4,750,725.19
Total dividends collected$148.7K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$5.25$136.00

Year-by-year: GBIO vs PLD ($10,000, DRIP)

YearGBIO PortfolioGBIO Income/yrPLD PortfolioPLD Income/yrGap
1$14,445$3,745.32$11,241$540.96+$3.2KGBIO
2$20,513$5,056.29$13,019$991.13+$7.5KGBIO
3$28,659$6,710.36$15,801$1,870.97+$12.9KGBIO
4$39,427$8,761.91$20,609$3,701.21+$18.8KGBIO
5$53,452$11,265.44$29,919$7,867.97+$23.5KGBIO
6$71,468$14,273.72$50,631$18,617.74+$20.8KGBIO
7← crossover$94,307$17,835.96$105,528$51,352.20$11.2KPLD
8$122,904$21,996.02$287,364$174,449.42$164.5KPLD
9$158,298$26,790.73$1,081,760$774,280.77$923.5KPLD
10$201,627$32,248.55$5,908,209$4,750,725.19$5.71MPLD

GBIO vs PLD: Complete Analysis 2026

GBIOStock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full GBIO Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this GBIO vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBIO vs SCHDGBIO vs JEPIGBIO vs OGBIO vs KOGBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.